Supplemental material
Human Vaccines & Immunotherapeutics
Volume 20, 2024 - Issue 1
Zoster
Attitudes, barriers, and facilitators to adherent completion of the recombinant zoster vaccine regimen in Canada: Qualitative interviews with healthcare providers and patients
Sydney Georgea GSK, Mississauga, ON, CanadaCorrespondence[email protected]
https://orcid.org/0000-0001-6274-9357View further author information
https://orcid.org/0000-0001-6274-9357View further author information, , , Meaghan O’Connorb QualityMetric Inc., Johnston, RI, USAhttps://orcid.org/0000-0001-6576-2952View further author information
https://orcid.org/0000-0001-6576-2952View further author information, April Fosterb QualityMetric Inc., Johnston, RI, USAhttps://orcid.org/0000-0002-9663-7510View further author information
https://orcid.org/0000-0002-9663-7510View further author information, Kimberly Raymondb QualityMetric Inc., Johnston, RI, USAhttps://orcid.org/0000-0001-9096-9269View further author information
https://orcid.org/0000-0001-9096-9269View further author information, Iris Gorfinkelc PrimeHealth Clinical Research, Toronto, ON, Canadahttps://orcid.org/0000-0002-8812-941XView further author information
https://orcid.org/0000-0002-8812-941XView further author information & Shelly A. McNeild Canadian Center for Vaccinology, IWK Health and Nova Scotia Health, Dalhousie University, Halifax, NS, Canadahttps://orcid.org/0000-0001-5444-4166View further author information
https://orcid.org/0000-0001-5444-4166View further author information show all